Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine-rich repeat containing 37 member A13, pseudogene (LRRC37A13P), is a processed pseudogene located in the human genome. It does not encode a protein and is not associated with any known disease mechanism or therapeutic target functions[1][2][3]. Processed pseudogenes like LRRC37A13P typically arise from retrotransposition events and lack the ability to encode functional proteins; their primary relevance is as genomic elements that may—very infrequently—play a regulatory role if transcribed, generally through microRNA decoy activity, but LRRC37A13P itself does not have any reported functional characterization[3][4]. If you expected a receptor, transporter, enzyme, or other drug target, this entry is therefore *not* suitable; it is best classified as a non-coding processed pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine-rich repeat containing 37 member A13, pseudogene (LRRC37A13P).